Without insurance, semaglutide costs $149 to about $1,349 a month for the medication alone: NovoCare lists the brand at $1,349.02 per package, with manufacturer self-pay at $149 to $399 a month by form and dose. InjectCo’s nurse-led Texas program is $425 a month, or $1,800 for 6 to 8 months, with consultation, compounded medication when prescribed, and home delivery.
Written by Kiara DeWitt, BSN, RN
Medically reviewed by Dr. Josh Allen, D.O., Medical Director on October 28, 2026
Medical disclaimer: Medical weight loss treatment is prescribed only after a clinical consultation and is not appropriate for everyone. Whether you are a candidate is decided by a licensed provider, not by any tool or information on this page. Results vary between individuals and depend on adherence, diet, and activity. Compounded medications are not FDA-approved.
Semaglutide prices range widely because each option includes different things. Some cover only the medication; others include visits, monitoring, and delivery. Here’s how the main options compare:
| Option | Monthly price | What it includes | Source |
|---|---|---|---|
| Brand (Wegovy) list price, pill or pen | $1,349.02 per package | Medication only, before discounts | NovoCare |
| Brand pill, manufacturer self-pay | $149 to $299 by dose | Medication only; prescription and visits separate | NovoCare |
| Brand pen, manufacturer self-pay | $349; new patients pay $199 a month for the first 2 months on the lowest strengths, through 31 Dec 2026 | Medication only; prescription and visits separate | NovoCare |
| Brand high-dose pen, manufacturer self-pay | $399 | Medication only; prescription and visits separate | NovoCare |
| Brand with commercial insurance and savings offer | As little as $25 (maximum savings $100 a month) | Medication only; requires commercial coverage of the drug | NovoCare |
| InjectCo nurse-led program | $425, or $1,800 for a 6 to 8 month program | Telehealth visits with nurse injectors, compounded medication when prescribed, home delivery, check-ins | InjectCo |
Prices checked 29 October 2026. Manufacturer prices come from NovoCare, are national, and can change; confirm with the source before relying on them.
The manufacturer figures are prices for the medication alone. You’d still need a prescriber, and any visits or monitoring are billed separately. The InjectCo row is an all-inclusive program price for compounded medication, which is a different product from the brand (see below).
The number you see first is rarely the number you pay. A few things drive the gap:
List price vs. paid price. The list price is set before discounts. NovoCare lists the brand at $1,349.02 per package, but people who pay cash can use the manufacturer’s lower self-pay prices instead.
Dose tiers. Manufacturer self-pay pricing changes by dose. NovoCare lists the brand pill at $149, $199, or $299 a month depending on the dose. An introductory price on a starter dose can look very different from the price a few months in.
Fees on top of the medication. Some providers advertise a low medication price, then add a monthly membership, platform, or visit fee. The advertised number covers only part of the bill.
The fairest comparison is one all-inclusive monthly price against another. Before comparing two quotes, ask each provider whether the number they give you is everything you’ll pay each month.
Compounded semaglutide is prepared by a licensed compounding pharmacy for an individual patient’s prescription, rather than manufactured and packaged by the brand’s maker. The FDA’s compounding questions and answers explain how that works.
Three points matter when you compare prices:
The FDA also states that compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug. Your provider should be able to explain plainly why a compounded medication is being recommended for you. For a fuller breakdown, see compounded vs brand-name semaglutide.
At the manufacturer’s self-pay prices, the pill starts lower: NovoCare lists the brand pill at $149 to $299 a month by dose, compared with $349 a month for the standard pen and $399 for the high-dose pen. New patients can pay $199 a month for the first 2 months of the pen’s lowest strengths, through 31 December 2026.
The pill has its own routine. According to the brand tablet prescribing information, you take it once a day on an empty stomach in the morning with up to 4 ounces of water, then wait at least 30 minutes before eating, drinking, or taking other oral medications. Some people find that easy; others prefer a weekly injection.
InjectCo’s needle-free option is different from the brand tablet. It’s compounded sublingual drops, at the same $425 a month as the injectable program.
It depends on your plan and on why the medication is prescribed. Coverage for weight management is often more limited than coverage for diabetes, and plans that do cover it often require prior authorization.
When you call your insurer, ask:
The $25 savings offer. If your commercial insurance covers the brand, NovoCare’s savings offer lets you pay as little as $25 a month, with maximum savings of $100 a month. It requires commercial coverage of the drug, so it doesn’t help if your plan excludes weight management or if you have no insurance.
Medicare. Medicare hasn’t traditionally covered medications used only for weight loss. The Medicare GLP-1 Bridge, a CMS demonstration running from 1 July 2026 through 31 December 2027, gives eligible Part D beneficiaries certain GLP-1 medications for a $50 copay, with prior authorization.
InjectCo’s medical weight loss program is $425 a month, or $1,800 for a 6 to 8 month program. That price includes:
The tirzepatide program is the same $425 a month. For a side-by-side, see tirzepatide cost without insurance.
To be fair about it, the cheaper route suits some people. If you’re already stable on a dose, comfortable managing your own treatment, and have a prescriber you trust, a medication-only option may be all you need. That’s a different choice, not a worse one. A program costs more because it builds in the visits, adjustments, and check-ins that a medication-only price leaves out.
IRS Publication 502 lets you include amounts you pay to lose weight as a medical expense if it is a treatment for a specific disease diagnosed by a physician, such as obesity. Whether your HSA or FSA covers your program depends on your plan administrator’s rules, so confirm with them first.
If you’d rather spread the cost, ask about payment options at your consultation.
Telehealth visits with our nurse injectors, medication when prescribed, and home delivery across Texas.
$425 a month, or $1,800 for a 6 to 8 month program
A quote that answers all five clearly is easier to compare than one that lists only a medication price.
Eligibility is decided during a medical evaluation. According to the brand tablet prescribing information, the brand is approved for use with a reduced-calorie diet and increased physical activity in adults with obesity, or adults with overweight and at least one weight-related condition.
The same label says not to use it if you or a family member have had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2, or if you’ve had a serious allergic reaction to semaglutide. It also includes warnings about conditions such as pancreatitis and gallbladder problems, which your provider will review with you.
For a closer look, read who should not take semaglutide.
According to NovoCare, the brand costs $149 to $399 a month at manufacturer self-pay prices: $149 to $299 for the pill by dose, $349 for the standard pen, and $399 for the high-dose pen. The brand’s list price is $1,349.02 per package, per NovoCare. InjectCo’s nurse-led program is $425 a month, including visits, compounded medication when prescribed, and delivery.
The lowest manufacturer self-pay price is the brand pill at $149 a month at its lowest dose, according to NovoCare. That price covers the medication only, so add the cost of a prescriber and any visits when you compare it with an all-inclusive program.
Usually, at manufacturer self-pay prices. NovoCare lists the pill at $149 to $299 a month by dose, compared with $349 for the standard pen.
Yes. A brand semaglutide tablet is FDA-approved for weight management and is taken once a day on an empty stomach. InjectCo’s needle-free option is compounded sublingual drops, which are not the brand tablet.
It varies by plan. Coverage for weight management is often limited and often requires prior authorization, so call your insurer and ask specifically about the weight management use.
Possibly. IRS Publication 502 allows weight-loss costs as a medical expense when they treat a specific disease diagnosed by a physician, such as obesity. Your plan administrator decides what it will reimburse, so check with them first.
No. Compounded semaglutide is not FDA-approved, is not a generic, and is not the same as brand-name semaglutide. According to the FDA, the agency does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
A nurse reviews your history and tells you what your plan costs before you commit.
$425 a month with home delivery
Dr. Allen earned his Doctor of Osteopathic Medicine at Lake Erie College of Osteopathic Medicine and completed his emergency medicine residency with Texas A&M. As Medical Director, he reviews InjectCo treatments, protocols, and patient education content for accuracy and safety across all nine Texas locations.
days day
hours hour
minutes minute
seconds second
